Headaches & Migraines
Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions? Dr. Ethan Russo (2004)
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes Dr. Ethan Russo (2016)
Cannabis For Migraines Dr. Ethan Russo (2019)
Short and Long Term Effects of Cannabis on Headache and Migraine U.S. Association for the Study of Pain (2020)
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study MDPI (2020)
Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users Complementary Therapies in Medicine (2021)
Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature Cureus (2021)
Medical Cannabis for Headache Pain: a Primer for Clinicians Current Pain and Headache Reports (2021)
Clinical Evidence of Cannabinoids in Migraine: A Narrative Review Journal of Clinical Medicine (2022)
Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence Frontiers in Neurology (2022)